Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab

Modern Rheumatology

Volumn 20, Issue 6, 2010, Pages 561-565

  Matsuno, Hiroaki ^a  

^a NONE

Author keywords

Cost; Etanercept; Half dose; Infliximab; Rheumatoid arthritis

Indexed keywords

BUCILLAMINE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INJECTION SITE REACTION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; JOINTS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650516698     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0320-8     Document Type: Article

References (20)

1. DA Fox 1995 Biological therapies: a novel approach to the treatment of autoimmune disease Am J Med 99 82 88 1:STN:280:DyaK2MzitFemtQ%3D%3D 7598148 10.1016/S0002-9343(99)80109-0
2. M Feldmann FM Brennan RN Maini 1996 Role of cytokines in rheumatoid arthritis Annu Rev Immunol 14 397 440 1:CAS:528:DyaK28XitlCgtb4%3D 8717520 10.1146/annurev.immunol.14.1.397 (Pubitemid 26130190)
3. MJ Elliott RN Maini M Feldmann A Long-Fox P Charles P Katsikis, et al. 1993 Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alfa Arthritis Rheum 36 1681 1690 1:STN:280: DyaK2c%2Fnt1SitA%3D%3D 8250987 10.1002/art.1780361206 (Pubitemid 23360007)
4. JS Smolen D Aletaha M Koeller MH Weisman P Emery 2007 New therapies for treatment of rheumatoid arthritis Lancet 370 9602 1861 1874 1:CAS:528: DC%2BD2sXhsVSgs7vF 17570481 10.1016/S0140-6736(07)60784-3 (Pubitemid 350180008)
5. H Matsuno 2008 Expensive medical expense and cost-reduction strategies in patients with rheumatoid arthritis Clin Rheumatol Related Res 39 548 554 (in Japanese; abstract in English)
6. G Gartlehner RA Hansen BL Jonas P Thieda KN Lohr 2006 The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and meta-analysis J Rheumatol 33 2398 2408 1:CAS:528:DC%2BD2sXhtVCntbk%3D 17225293 (Pubitemid 46067817)
7. DM Van der Heijde PL van Riel IH Nuver-Zwart FW Gribnau LB van de Putte 1989 Effect of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1 1036 1038 2565997 (Pubitemid 19123055)
8. HA Fuchs JJ Kaye LF Callahan EP Nance T Pincus 1989 Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease J Rheumatol 16 585 591 1:STN:280:DyaL1MzivV2jsA%3D%3D 2754663 (Pubitemid 19154397)
9. JR O'Dell 2002 Treating rheumatoid arthritis; a window of opportunity? Arthritis Rheum 46 283 285 11840429 10.1002/art.10092 (Pubitemid 34136564)
10. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 2002; 46:328-46.
11. R Maini EW St Clair F Breedveld D Furst J Kalden M Weisman, et al. 1999 Inflixamab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 354 9194 1932 1939 1:CAS:528:DC%2BD3cXit1Oquw%3D%3D 10622295 10.1016/S0140-6736(99)05246- 0
12. LW Moreland MH Schiff SW Baumgartner EA Tindall RM Fleischmann KJ Bulpitt, et al. 1999 Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial Ann Intern Med 130 478 486 1:CAS:528:DyaK1MXitFChs7Y%3D 10075615 (Pubitemid 29135800)
13. D van der Heijde L Klareskog V Rodriguez-Valverde C Codreanu H Bolosiu J Melo-Gomes, et al. 2006 Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial Arthritis Rheum 54 1063 1074 16572441 10.1002/art.21655 (Pubitemid 43672919)
14. FC Breedveld MH Weisman AF Kavanaugh, et al. 2006 The PREMIER study: a multicentre, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26 1:CAS:528:DC%2BD28XhsVens74%3D 16385520 10.1002/art.21519 (Pubitemid 43122183)
15. LB van de Putte R Rau FC Breedveld JR Kalden MG Malaise PL van Riel, et al. 2003 Efficacy and safety of the fully human anti-tumor necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study Ann Rheum Dis 62 1168 1177 14644854 10.1136/ard.2003.009563 (Pubitemid 37500622)
16. JJ Gomez-Reino L Carmona BIOBADASER group 2006 Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period Arthritis Res Ther 8 R29 16507128 10.1186/ar1881
17. KI Hyrich M Lunt KD Watson DP Symmons AJ Silman 2007 Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study Arthritis Rheum 56 13 20 1:CAS:528: DC%2BD2sXhsFaisrw%3D 17195186 10.1002/art.22331 (Pubitemid 46106174)
18. DE Furst N Gaylis V Bray E Olech D Yocum J Ritter, et al. 2007 Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study Ann Rheum Dis 66 893 899 1:CAS:528:DC%2BD2sXotlSitL4%3D 17412737 10.1136/ard.2006.068304 (Pubitemid 46999789)
19. JM Berthelot S Varin G Cormier L Tortellier P Guillot J Glemarec, et al. 2007 25 mg etanercept once weekly in rheumatoid arthritis and spondylarthropathy Joint Bone Spine 74 144 147 1:CAS:528:DC%2BD2sXms1Srsb4%3D 17337351 10.1016/j.jbspin.2006.03.010 (Pubitemid 46603017)
20. JS Smolen D Aletaha M Koeller MH Weisman P Emery 2007 New therapies for treatment of rheumatoid arthritis Lancet 370 1861 1874 1:CAS:528: DC%2BD2sXhsVSgs7vF 17570481 10.1016/S0140-6736(07)60784-3 (Pubitemid 350180008)